Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Magnesium Therapy in Acute Stroke
NCT01502761Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Mar 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of magnesium sulfate in ischemic stroke (4 arms), sponsored by University of Southern California. Primary endpoint: Magnesium Concentration in Region of Cerebral Ischemia at 1 day. Started Mar 2012; status: terminated.
02
Drugs
magnesium sulfate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01502761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01502761.